164 related articles for article (PubMed ID: 31817500)
1. Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma using Magnetic Resonance Images: A Literature Review.
Suzuki A; Aoki M; Miyagawa C; Murakami K; Takaya H; Kotani Y; Nakai H; Matsumura N
Healthcare (Basel); 2019 Dec; 7(4):. PubMed ID: 31817500
[TBL] [Abstract][Full Text] [Related]
2. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
[TBL] [Abstract][Full Text] [Related]
3. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
4. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma.
Bi Q; Xiao Z; Lv F; Liu Y; Zou C; Shen Y
Acad Radiol; 2018 Aug; 25(8):993-1002. PubMed ID: 29422425
[TBL] [Abstract][Full Text] [Related]
5. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
[TBL] [Abstract][Full Text] [Related]
8. Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma.
Kawamura N; Ichimura T; Ito F; Shibata S; Takahashi K; Tsujimura A; Ishiko O; Haba T; Wakasa K; Ogita S
Cancer; 2002 Mar; 94(6):1713-20. PubMed ID: 11920533
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
[TBL] [Abstract][Full Text] [Related]
10. A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Oda S; Sakamoto F; Shiraishi S; Yamashita Y
Clin Radiol; 2019 Feb; 74(2):167.e1-167.e7. PubMed ID: 30471748
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging features of uterine sarcoma and mimickers.
Barral M; Placé V; Dautry R; Bendavid S; Cornelis F; Foucher R; Guerrache Y; Soyer P
Abdom Radiol (NY); 2017 Jun; 42(6):1762-1772. PubMed ID: 28246921
[TBL] [Abstract][Full Text] [Related]
12. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902
[TBL] [Abstract][Full Text] [Related]
14. Uterine sarcoma vs adenocarcinoma: can MRI distinguish between them?
Hernández Mateo P; Méndez Fernández R; Serrano Tamayo E
Radiologia; 2016; 58(3):199-206. PubMed ID: 26617259
[TBL] [Abstract][Full Text] [Related]
15. Preliminary utilization of radiomics in differentiating uterine sarcoma from atypical leiomyoma: Comparison on diagnostic efficacy of MRI features and radiomic features.
Xie H; Hu J; Zhang X; Ma S; Liu Y; Wang X
Eur J Radiol; 2019 Jun; 115():39-45. PubMed ID: 31084757
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
[TBL] [Abstract][Full Text] [Related]
17. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J
Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902
[TBL] [Abstract][Full Text] [Related]
18. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.
Bonneau C; Thomassin-Naggara I; Dechoux S; Cortez A; Darai E; Rouzier R
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):261-8. PubMed ID: 24372487
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging Grading System for Preoperative Diagnosis of Leiomyomas and Uterine Smooth Muscle Tumors.
Suzuki Y; Wada S; Nakajima A; Fukushi Y; Hayashi M; Matsuda T; Asano R; Sakurai Y; Noguchi H; Shinohara T; Sato C; Fujino T
J Minim Invasive Gynecol; 2018; 25(3):507-513. PubMed ID: 29079462
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of susceptibility-weighted MR sequence for the evaluation of uterine sarcomas.
Takeuchi M; Matsuzaki K; Harada M
Clin Imaging; 2019; 53():143-150. PubMed ID: 30340078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]